GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » Cyclically Adjusted FCF per Share

Vitrolife AB (FRA:VTFN) Cyclically Adjusted FCF per Share : €0.33 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Vitrolife AB's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.104. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.33 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Vitrolife AB's average Cyclically Adjusted FCF Growth Rate was 17.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 23.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Vitrolife AB was 23.10% per year. The lowest was 14.80% per year. And the median was 22.50% per year.

As of today (2024-06-24), Vitrolife AB's current stock price is €15.36. Vitrolife AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €0.33. Vitrolife AB's Cyclically Adjusted Price-to-FCF of today is 46.55.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Vitrolife AB was 236.86. The lowest was 35.08. And the median was 102.66.


Vitrolife AB Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Vitrolife AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Cyclically Adjusted FCF per Share Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.20 - 0.29 0.34

Vitrolife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.29 0.29 0.31 0.34 0.33

Competitive Comparison of Vitrolife AB's Cyclically Adjusted FCF per Share

For the Medical Devices subindustry, Vitrolife AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Cyclically Adjusted Price-to-FCF falls into.



Vitrolife AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vitrolife AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.104/132.2054*132.2054
=0.104

Current CPI (Mar. 2024) = 132.2054.

Vitrolife AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.032 100.432 0.042
201409 0.060 100.161 0.079
201412 0.038 100.225 0.050
201503 0.008 99.950 0.011
201506 0.031 99.995 0.041
201509 0.058 100.228 0.077
201512 0.094 100.276 0.124
201603 0.010 100.751 0.013
201606 0.045 101.019 0.059
201609 0.045 101.138 0.059
201612 0.075 102.022 0.097
201703 0.032 102.022 0.041
201706 0.079 102.752 0.102
201709 0.082 103.279 0.105
201712 0.102 103.793 0.130
201803 0.038 103.962 0.048
201806 0.094 104.875 0.118
201809 0.076 105.679 0.095
201812 0.104 105.912 0.130
201903 0.022 105.886 0.027
201906 0.039 106.742 0.048
201909 0.128 107.214 0.158
201912 0.094 107.766 0.115
202003 0.012 106.563 0.015
202006 0.054 107.498 0.066
202009 0.085 107.635 0.104
202012 0.155 108.296 0.189
202103 0.130 108.360 0.159
202106 0.121 108.928 0.147
202109 0.090 110.338 0.108
202112 0.000 112.486 0.000
202203 0.063 114.825 0.073
202206 0.125 118.384 0.140
202209 0.137 122.296 0.148
202212 0.112 126.365 0.117
202303 0.094 127.042 0.098
202306 0.134 129.407 0.137
202309 0.134 130.224 0.136
202312 0.113 131.912 0.113
202403 0.104 132.205 0.104

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Vitrolife AB  (FRA:VTFN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Vitrolife AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=15.36/0.33
=46.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Vitrolife AB was 236.86. The lowest was 35.08. And the median was 102.66.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Vitrolife AB Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB (FRA:VTFN) Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (FRA:VTFN) Headlines

No Headlines